NCT00553215

Quality of Life in Patients With Bladder Cancer

Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [QOL]

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,700 (planned)
• Sponsor: University of Birmingham · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Studying quality of life in patients with bladder cancer may help determine the long-term effects of bladder cancer and may help improve the quality of life for patients in the future. PURPOSE: This clinical trial is studying quality of life in patients with bladder cancer.

Detailed description

OBJECTIVES: * To study the effects of recurrence and progression on health-related quality of life (HRQL). * To study the effects of repeat cystoscopy on HRQL. * To study the patients' assessments of a hypothetical prognostic model and how this affects their preference for the mode of surveillance. OUTLINE: This is a multicenter study. Quality-of-life questionnaires developed by the European Organization for Research and Treatment for Cancer (EORTC) will be used. The EORTC QLQ-BLS24 with 24 questions specific to non-muscle-invasive bladder cancer and the EORTC QLQ-BLM30 with 30 questions specific to muscle-invasive bladder cancer will be combined and used in conjunction with the general cancer questionnaire QLQ-C30. Assessments using the QLQ-C30 will be made at baseline in the entire cohort of patients. Follow-up assessments using the QLQ-C30, QLQ-BLS24, and QLQ-BLM30 167 will be made at first routine follow-up and annually until the end of study. Peer Reviewed and Funded or Endorsed by Cancer Research UK.

Conditions

• Bladder Cancer

Interventions

Type	Name	Description
PROCEDURE	quality-of-life assessment
PROCEDURE	questionnaire administration

Timeline

• Start date: 2005-12-01
• First posted: 2007-11-05
• Last updated: 2014-01-10

Locations

1 site across 1 country: United Kingdom